Accelus
Private Company
Total funding raised: $85M
Overview
Accelus is an emerging player in the spine surgery device sector, formed to advance minimally invasive surgical (MIS) techniques. The company leverages a portfolio of integrated technologies, including implants, instruments, and enabling software, targeting a significant global market for spinal disorders. As a private entity, it operates in a highly competitive landscape dominated by large, established medtech firms, with its success hinging on clinical adoption, execution, and potential future funding.
Technology Platform
Integrated platform of minimally invasive spinal implants, specialized surgical instruments, and enabling software for procedural planning and execution.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
The spine surgery market is dominated by large players like Medtronic, Stryker, Johnson & Johnson (DePuy Synthes), and Globus Medical, along with strong pure-play competitors like NuVasive and SeaSpine. Accelus must differentiate on technology, price, surgeon training, and service to compete effectively in this crowded field.